Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Revenue: 2014-2024

Historic Revenue for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to $631.4 million.

  • Collegium Pharmaceutical's Revenue rose 31.42% to $209.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $757.1 million, marking a year-over-year increase of 26.34%. This contributed to the annual value of $631.4 million for FY2024, which is 11.41% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Revenue is $631.4 million, which was up 11.41% from $566.8 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Revenue registered a high of $631.4 million during FY2024, and its lowest value of $276.9 million during FY2021.
  • Over the past 3 years, Collegium Pharmaceutical's median Revenue value was $566.8 million (recorded in 2023), while the average stood at $554.0 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Revenue declined by 10.69% in 2021 and then spiked by 67.56% in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's Revenue (Yearly) stood at $310.0 million in 2020, then declined by 10.69% to $276.9 million in 2021, then skyrocketed by 67.56% to $463.9 million in 2022, then grew by 22.17% to $566.8 million in 2023, then increased by 11.41% to $631.4 million in 2024.